Clinical Trials in Atlanta

Showing 5621-5640 of 19,805 trials

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

NCT04943900

The purpose of this study is to evaluate the safety, tolerability, drug effects, drug levels and preliminary antitumor activity of BMS-986416 when administered alone and in combination with Nivolumab in participants with select advanced solid tumors.

Advanced Solid Tumors

Bristol-Myers Squibb67 participantsStarted Aug 2021

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Hackensack, New Jersey, United States +16 more locations

TERMINATEDPhase 3< 1 mile

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

NCT03192215

Objectives * Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial cardiopathy. * Secondary: To test the hypothesis that the relative efficacy of apixaban over aspirin increases with the severity of atrial cardiopathy.

Stroke

Columbia University1,015 participantsStarted Jan 2018

Birmingham, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +174 more locations

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Find Trials by Condition in Atlanta

FEED-Cystic Fibrosis (FEED-CF)

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Safety Study of XT-150 in Participants With ALS

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors

An Innovative Treatment for Cervical Precancer (UH3)